Home/Filings/4/0001140361-18-003375
4//SEC Filing

Kavanaugh William Michael 4

Accession 0001140361-18-003375

CIK 0001501989other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 2:54 PM ET

Size

13.9 KB

Accession

0001140361-18-003375

Insider Transaction Report

Form 4
Period: 2018-01-24
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
  • Award

    Stock Option (right to buy)

    2018-01-24+75,00075,000 total
    Exercise: $25.82Exp: 2028-01-23Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0001578767

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 2:54 PM ET
Size
13.9 KB